Articles by Susan J. Schniepp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan J. Schniepp

Auditing by the Numbers

Contract organizations must have highly organized teams and plans to accommodate today's audits.
Dec 2, 2011

Contract organizations must have highly organized teams and plans to accommodate today's audits.

Where in the World is the US Pharmacopeia?

After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.
Sep 2, 2011

After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.

Following our Own Instructions

Why SOPs are rarely followed, often cited, and in need of follow-through.
Jun 2, 2011

Why SOPs are rarely followed, often cited, and in need of follow-through.

Insider Solutions: Reporting Equipment Changes

What to do when your CMO changes the manufacturing equipment line.
Mar 2, 2011

What to do when your CMO changes the manufacturing equipment line.

Insider Solutions Rule #1: Be in Compliance

Drug manufacturers have to be more than just "audit ready."
Nov 2, 2010

Drug manufacturers have to be more than just "audit ready."

Insider Solutions: The Quality Agreement

Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.
Aug 2, 2010

Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.

Inside USP: The USP Convention

Defining the Next Five Years.
May 2, 2010

Defining the Next Five Years.

USP Convention Sets Agenda for Next Five Years

Apr 29, 2010

The US Pharmacopeial Convention recently held its convention in Washington, DC.

ISPE Raises the Bar for Baseline Guides

New information improves an organization's guide to building manufacturing facilities.
Apr 2, 2010

New information improves an organization's guide to building manufacturing facilities.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here